Jonathan M Cohen insider trades

Open-market stock purchases and sales by Jonathan M Cohen, Chief Executive Officer at 20/20 Biolabs, Inc, from SEC Form 4 filings since Mar 3, 2026.

Recent trades

DateStockTradeValue
Mar 3, 2026AIDX 20/20 Biolabs, IncBought (not open market)—

Companies traded

  • AIDX 20/20 Biolabs, Inc: other filings, last Mar 3, 2026

Get free alerts when Jonathan M Cohen files a new trade →